It was reported that this implantable pacemaker device exhibited longevity calculation with six months remaining.Boston scientific technical services (ts) discussed that the device power consumption does seem high for usage and submitted data for analysis.Data analysis confirmed that the power consumption is increasing in a gradual fashion.Despite the premature battery depletion (pbd) condition, there is sufficient capacity to support therapy for at least ninety days.The device remains in service.No adverse patient effects were reported.
|